# US 2010/0167405 A1 · Processes for improved strain engineering

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167405 A1
- Document ID: US20100167405A1
- Status: Published application
- Kind: A1
- Application number: 12/601,505
- Filed: 2008-05-22
- Published: 2010-07-01
- Earliest claimed: 2007-05-24
- Assignees: Nature Technology Corporation
- Inventors: James A. Williams
- Web page: https://patentgrep.com/patent/US20100167405A1

## CPC

- C12N 15/902: {using homologous recombination}
- C12N 15/1079: {Screening libraries by altering the phenotype or phenotypic trait of the host (reporter assays C12N15/1086)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Improvements in strain engineering technology are needed to insure the economic feasibility of future engineered recombinant organisms for industrial biotechnology. Disclosed herein are rapid, efficient methods (Genome Mass Transfer) that facilitate introduction of new selectable traits into a target microbial host. In one preferred embodiment, methods for high efficiency electroporation mediated transfer of donor DNA into a recipient microbial cell are disclosed.

## Claims

### Claim 1

A method for engineering microbial cells comprising the steps of:
a. isolating genomic DNA from a donor strain; and
b. introduction of donor DNA into a recipient strain engineered to express recombineering genes; and
c. selecting for acquisition of a trait in the recipient host;
whereby said method increases the frequency of targeted incorporation of said donor DNA into said recipient host's genome.

### Claim 2 (depends on 1)

2) The method of claim 1 wherein said microbial cells are E. coli.

### Claim 3 (depends on 1)

3) The method of claim 1 wherein said recombineering genes are lambda red, gam and/or exo or recET.

### Claim 4 (depends on 1)

4) The method of claim 1 wherein said recombineering genes are transiently expressed from a conditional replication origin containing plasmid.

### Claim 5 (depends on 1)

5) The method of claim 1 wherein the said genomic DNA from a donor strain is introduced into said recipient strain by electroporation.

### Claim 6 (depends on 1)

6) The method of claim 1 wherein said step of isolating genomic DNA from a donor strain is performed by amplification of DNA from a donor cell lysate.

### Claim 7 (depends on 1)

7) The method of claim 1 wherein said trait is an antibiotic resistant transposon insert that increases or decreases expression of a gene of interest.

### Claim 8

8) A method for engineering cells comprising the steps of:
a. isolating genomic DNA from a donor strain; and
b. introduction of donor DNA into a recipient strain of the same or different species, which said recipient strain is engineered to express recombineering genes; and
c. selecting for acquisition of a trait in the recipient host;
whereby said method increases the frequency of targeted incorporation of said donor DNA into said recipient host's genome.

### Claim 9 (depends on 8)

9) The method of claim 8, wherein said cells may include prokaryotic and/or eukaryotic cells, including zygotes, embryos, tissues and organisms.

### Claim 10 (depends on 8)

10) The method of claim 8 wherein said recombineering genes are expressed by at least one means selected from the group consisting of: transient expression; from co-transfected genes or plasmids; from a conditional replication origin containing plasmid; or from integrated nucleic acid sequences.

### Claim 11 (depends on 8)

11) The method of claim 8 wherein the said genomic DNA from a donor strain is introduced into said recipient strain by means of at least one mechanism selected from the following group: electroporation; transfection; liposomes; cationic lipids or polymers; calcium phosphate; carbon nanorods; or gene gun.

### Claim 12 (depends on 8)

12) The method of claim 8 wherein said step of isolating genomic DNA from a donor strain is performed by amplification of DNA from a donor cell lysate.
